Journal of Jilin University Medicine Edition ›› 2017, Vol. 43 ›› Issue (04): 762-769.doi: 10.13481/j.1671-587x.20170420

Previous Articles     Next Articles

Dexmedetomidine and midazolam in procedural sedation:a systematic review of efficacy and safety

DING Xianfei, YUAN Bo, XU Zhentao, ZHENG Shaohua, MA Yan, SHI Peina, SUN Tongwen   

  1. General ICU, First Affiliated Hospital, Zhengzhou University, Henan Key Laboratory of Critical Care Medicine, Zhengzhou 450052, China
  • Received:2017-04-08 Online:2017-07-28 Published:2017-08-01

Abstract: Objective: To systematically review the efficacy and safety of dexmedetomidine and midazolam in procedural sedation.Methods: PubMed,EMBase,Cochrane Library,CNKI,CBM and WanFang databases were retrieved to collect the randomized controlled trials (RCT) about comparion of efficacy and safety between dexmedetomidine and midazolam in procedural sedation up to March, 2017. Based on the inclusion criteria, the data extraction and quality evaluation were performed, and then the systematic evaluation was carried out.The outcome measures for efficacy were the satisfaction scores and pain scores of the patients and clinicians;the outcome measures for safety comparison were hypotension, hypoxia, and circulatory and respiratory complications.Results: There were 14 RCT satisfied the inclusion criteria including 949 patients. Compared with midazolam group, the incidence of pain, delirium, and analgesia of the patients in dexmedetomidine group had significant differences (P<0.05); but the incidence of respiratory depression, low blood pressure had no significant differences (P>0.05).Conclusion: When the adult patients are sedated, dexmedetomidine can be used as an ideal alternative to midazolam sedation.

Key words: Jadad scale, systematic review, dexmedetomidine, midazolam, procedural sedation

CLC Number: 

  • R614